Rick Tang

Rick Tang is a California lawyer who has lived and worked in six countries in investment for over 30 years. He now splits his time between managing his family assets and philanthropy. Rick serves as a trustee and chairman of grants allocation for Fu Tak Iam Foundation. He also teaches HKU students and NGO managers how to raise funds from family foundations.
Rick Tang
Rick Tang is a California lawyer who has lived and worked in six countries in investment for over 30 years. He now splits his time between managing his family assets and philanthropy. Rick serves as a trustee and chairman of grants allocation for Fu Tak Iam Foundation. He also teaches HKU students and NGO managers how to raise funds from family foundations.

Latest from Rick Tang

Why it is in US interests to accept China as an equal in the Asia-Pacific
Protesters must clear the roads, or be cleared by force

The young people who have been occupying the main arteries of Hong Kong have acted in a responsible manner. Most of them exercise restraint.

7 Oct 2014 - 4:11AM

The young people who have been occupying the main arteries of Hong Kong have acted in a responsible manner. Most of them exercise restraint.

Protesters must clear the roads, or be cleared by force
Embracing the rule of law wouldhelp realise the Chinese Dream

When President Xi Jinping came into office in November 2012, he declared that he would strike the "tigers" and the "flies" in a crackdown on corruption. Since then, over 37 "tigers" and many "flies" have been caught, the latest being former security chief Zhou Yongkang.

4 Aug 2014 - 2:46AM

When President Xi Jinping came into office in November 2012, he declared that he would strike the "tigers" and the "flies" in a crackdown on corruption. Since then, over 37 "tigers" and many "flies" have been caught, the latest being former security chief Zhou Yongkang.

Embracing the rule of law wouldhelp realise the Chinese Dream
China's GSK probe motivated solely by wish to curb corruption

The major pharmaceutical multinational GlaxoSmithKline is being investigated by the Chinese authorities for anti-trust and bribery offences. It is alleged that the company's management in China orchestrated an industry-wide bribery scheme to designate GSK's products as the "drugs of choice" for patients. The scheme involved paying bribes to professionals in the medical, hospital and pharmaceutical industry.

9 Sep 2013 - 2:47AM

The major pharmaceutical multinational GlaxoSmithKline is being investigated by the Chinese authorities for anti-trust and bribery offences. It is alleged that the company's management in China orchestrated an industry-wide bribery scheme to designate GSK's products as the "drugs of choice" for patients. The scheme involved paying bribes to professionals in the medical, hospital and pharmaceutical industry.

China's GSK probe motivated solely by wish to curb corruption